CLL Clinical Trials
3 recruiting trials for CLL. Eligibility criteria explained in plain English.
3
Total Trials
3
Recruiting Now
0
Phase 3 Trials
3
Sponsors
Recruiting Trials
RECRUITINGPhase 1 / Phase 2NCT05869279
Allogeneic CARCIK-CD19 in Adults/Pediatric B-cell NHL or Chronic Lymphocytic Leukemia
This is a single arm, open-label, multi-center, phase I/II study to determine the engraftment, safety and clinical activity of allogeneic CARCIK-CD19 cells in adult and pediatric...
Sponsor: Fondazione Matilde Tettamanti Menotti De Marchi OnlusEnrolling: 291 location
RECRUITINGNCT05246345
Venetoclax Resistance Landscape in Chronic Lymphocytic Leukemia
The purpose of this study is to collect medical informations and samples from refractory and/or relapsed chronic lymphocytic leukemia during or after venetoclax treatment, in...
Sponsor: University Hospital, Clermont-FerrandEnrolling: 5014 locations
RECRUITINGPhase 2NCT07108998
Study of Epcoritamab as a Consolidation Therapy in CLL/SLL
This is a phase 2 study of Epcoritamab as a consolidation therapy for 2nd generation BTKi +/- Obinutuzumab in CLL/SLL patients or patients with variants of this.
Sponsor: Zulfa OmerEnrolling: 221 location